5-17 | Médecins Sans Frontières/Doctors Without Borders (MSF) are pleased that, having shared the results of TB-PRACTECAL, our clinical trial that found a new, safer and more effective six-month oral treatment regimen for multi drug-resistant tuberculosis (MDR-TB), the World Health Organization (WHO) have announced it will update global guidance on treatment. Following the results of MSF’s trial the WHO are now recommending programmatic use of the 6- month BPaLM regimen – comprising bedaquiline, pretomanid, linezolid (600 mg) and moxifloxacin in MDR-TB patients in pla
3-18 | Flashquote by MSF-Spain president Paula Gil: “Today, March 17, The New York Times published an investigation into the killings of our colleagues María Hernández, Tedros Gebremariam, and Yohannes Halefom in Tigray, Ethiopia, on June 24, 2021.
2-26 | Médecins Sans Frontières (MSF)'s statement on the escalating situation in Ukraine.
2-26 | Médecins Sans Frontières (MSF)'s statement on the escalating situation in Ukraine.
2-17 | CAPE TOWN - A vaccination support programme developed by MSF in Khayelitsha, South Africa, in partnership with the Western Cape Department of Health (WCDoH), has shown that it is possible to target and protect individuals with comorbidities that increase the risk of severe disease and death from COVID-19.